Sensei Biotherapeutics (United States)

Oxidative Damage Is the Earliest Event in Alzheimer Disease

Akihiko Nunomura, George Perry, Gjumrakch Aliev et al. · Journal of Neuropathology & Experimental Neurology · 2001 · 1.8K citations · Full text

The Ability of an Oligomeric Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Antigen To Elicit Neutralizing Antibodies against Primary HIV-1 Isolates Is Improved following Partial Deletion of the Second Hypervariable Region

Susan W. Barnett, Shan Lu, I Srivastava et al. · Journal of Virology · 2001 · 218 citations · Full text

Immunology, Viral Pathogenesis, Viral Structural Protein +16

Phase I and II Study of the Safety, Virologic Effect, and Pharmacokinetics/Pharmacodynamics of Single-Dose 3-<i>O</i>-(3′,3′-Dimethylsuccinyl)Betulinic Acid (Bevirimat) against Human Immunodeficiency Virus Infection

Patrick F. Smith, Abayomi Ogundele, Alan Forrest et al. · Antimicrobial Agents and Chemotherapy · 2007 · 192 citations · Full text

Induction of Potent Immune Responses by Cationic Microparticles with Adsorbed Human Immunodeficiency Virus DNA Vaccines

Derek T. O’Hagan, Manmohan Singh, Mildred Ugozzoli et al. · Journal of Virology · 2001 · 178 citations · Full text

Ectopic localization of phosphorylated histone H3 in Alzheimer's disease: a mitotic catastrophe?

Osamu Ogawa, Xiongwei Zhu, Hyoung‐gon Lee et al. · Acta Neuropathologica · 2003 · 170 citations

Chromatin, Alzheimer's Disease, Chromatin Remodeling +10